In a study published on line this week in the journal Human Molecular Genetics, Drs. Donita Garland, Rosario Fernandez-Godino, and Eric Pierce of the Ocular Genomics Institute at the Massachusetts Eye and Ear, Harvard Medical School, along with their c…
Structure of Polypoidal Choroidal Vasculopathy Studied by Colocalization Between Tomographic and Angiographic Lesions – Corrected Proof
Purpose: To investigate the structure of polypoidal choroidal vasculopathy (PCV) by tomographic localization of the branching vascular network and late geographic hyperfluorescence.Design: Observational case series.Methods: We examined 34 eyes with PCV…
Mucosal Complications of Modified Osteo-odonto Keratoprosthesis in Chronic Stevens-Johnson Syndrome – Corrected Proof
Purpose: To describe clinical outcomes of complications afflicting the autologous oral mucous membrane graft after modified osteo-odonto keratoprosthesis surgery in chronic Stevens-Johnson syndrome (SJS).Design: Prospective case series.Methods: This st…
The Death of the Medical Expert?
A look at the good — but mostly bad — effects of the ‘democratization’ of medicine. Medscape Psychiatry
Uncategorized
Quality, access or efficiency? Proposals to fix SGR attempt to meet all three goals
For two parties that rarely agree on anything, Republicans and Democrats from both houses of Congress have found common ground on one issue: Medicare’s sustainable growth rate (SGR) formula for calculating physician reimbursement is broken. It remains to be seen, however, whether that bipartisan consensus means that the problem can be fixed.Medicare payments to participating physicians have been linked for more than 10 years to changes in the country’s gross domestic product through the SGR. As discussed in previous coverage, the SGR reduces physician payments automatically if program spending exceeds (Read more...)
Uncategorized
Abbott finalizes purchase of OptiMedica
Abbott has completed its entry into the femtosecond laser-assisted cataract surgery market with the completion of its acquisition of OptiMedica, the company said in a news release.“OptiMedica’s technology, combined with Abbott’s global market presence, offer the potential to provide advanced cataract treatment options to more patients around the world,” Murthy Simhambhatla, PhD, senior vice president of Abbott Medical Optics, said in the release.